Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RISEDRONAT ARENA 5 mg
Bisphosphonate indicated in the treatment and prevention of osteoporosis
Active Substance (INN)
ACIDUM RISEDRONICUM
Packaging
blister x 15; 2 x 15; 6 x 15 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.